Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -248.21% is 122% below its 5-year average of -111.71%, near the low end of its 5-year range (-248.21%–-12.45%).
As of the fiscal period ended Tuesday, June 30, 2026. 26.61% below its 12-month average of -196.05%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -248.21%.
RETURN ON INVESTED CAPITAL (ROIC)
-248.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-196.05%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-162.52%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-111.71%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-26.61%
CURRENT VS 3Y AVG
-52.73%
CURRENT VS 5Y AVG
-122.20%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.44%
median of 760 covered companies
CURRENT VS SECTOR MEDIAN
-620.82%
vs the sector median at left
LeonaBio, Inc.
Market Cap
$22.36M
Return on Invested Capital (ROIC)
-248.21%
TTM Avg
-196.05%
3Y Avg
-162.52%
5Y Avg
-111.71%
Market Cap
$22.11M
Return on Invested Capital (ROIC)
-14.21%
TTM Avg
-12.54%
3Y Avg
-12.42%
5Y Avg
-37.50%
Market Cap
$21.76M
Return on Invested Capital (ROIC)
-253.57%
TTM Avg
-160.85%
3Y Avg
-171.27%
5Y Avg
-226.34%
Market Cap
$22.98M
Return on Invested Capital (ROIC)
-36.89%
TTM Avg
-112.27%
3Y Avg
-56.18%
5Y Avg
-37.49%
Market Cap
$20.99M
Return on Invested Capital (ROIC)
-27.14%
TTM Avg
-181.80%
3Y Avg
-158.13%
5Y Avg
-129.64%
Market Cap
$24.09M
Return on Invested Capital (ROIC)
-78.16%
TTM Avg
-118.00%
3Y Avg
-120.55%
5Y Avg
-93.95%
Market Cap
$24.67M
Return on Invested Capital (ROIC)
-146.30%
TTM Avg
-66.51%
3Y Avg
-47.74%
5Y Avg
-43.26%
Market Cap
$24.70M
Return on Invested Capital (ROIC)
-53.34%
TTM Avg
-80.89%
3Y Avg
-129.43%
5Y Avg
-113.96%
Market Cap
$20.01M
Return on Invested Capital (ROIC)
-1489.99%
TTM Avg
-2573.36%
3Y Avg
-1757.31%
5Y Avg
-1757.31%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LeonaBio, Inc. (LONA) | $22.36M | -248.21% | -196.05% | -162.52% | -111.71% |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.11M | -14.21% | -12.54% | -12.42% | -37.50% |
| Modular Medical, Inc. (MODD)vs › | $21.76M | -253.57% | -160.85% | -171.27% | -226.34% |
| Rein Therapeutics Inc. (RNTX)vs › | $22.98M | -36.89% | -112.27% | -56.18% | -37.49% |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.99M | -27.14% | -181.80% | -158.13% | -129.64% |
| Kyntra Bio, Inc. (KYNB)vs › | $24.09M | -78.16% | -118.00% | -120.55% | -93.95% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.67M | -146.30% | -66.51% | -47.74% | -43.26% |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.70M | -53.34% | -80.89% | -129.43% | -113.96% |
| Actuate Therapeutics Inc (ACTU)vs › | $20.01M | -1489.99% | -2573.36% | -1757.31% | -1757.31% |
| P3 Health Partners Inc. (PIII)vs › | $19.67M | -51.68% | -130.81% | -134.17% | -120.84% |
ROIC
-248.2%
ROE
-421.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -248.21% |
| 2026-03-31 | -170.77% |
| 2025-12-31 | -229.05% |
| 2025-09-30 | -141.77% |
| 2025-06-30 | -190.44% |
| 2025-03-31 | -217.65% |
| 2024-12-31 | -221.06% |
| 2024-09-30 | -195.49% |
| 2024-06-30 | -141.99% |
| 2024-03-31 | -114.39% |
| 2023-12-31 | -95.48% |
| 2023-09-30 | -82.89% |
| 2023-06-30 | -63.56% |
| 2023-03-31 | -51.92% |
| 2022-12-31 | -43.94% |
| 2022-09-30 | -34.05% |
| 2022-06-30 | -29.60% |
| 2022-03-31 | -25.25% |
| 2021-12-31 | -19.84% |
| 2021-09-30 | -16.07% |
| 2021-06-30 | -12.45% |
| 2021-03-31 | -8.09% |
| 2020-12-31 | -7.27% |
| 2020-09-30 | -4.62% |
| 2020-06-30 | -7.58% |
| 2019-12-31 | -594.87% |
